Related references
Note: Only part of the references are listed.Anti-JC Virus Antibodies: Implications for PML Risk Stratification
Leonid Gorelik et al.
ANNALS OF NEUROLOGY (2010)
Progressive Multifocal Leukoencephalopathy and Newer Biological Agents
Joseph R. Berger
DRUG SAFETY (2010)
Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
Edward J. Fox
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Characterization of JC Human Polyomavirus Infection in a Portuguese Population
Ana Matos et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
David B. Clifford et al.
LANCET NEUROLOGY (2010)
Progressive Multifocal Leukoencephalopathy Deaths in the USA, 1979-2005
Krista L. Yorita Christensen et al.
NEUROEPIDEMIOLOGY (2010)
Incidence of progressive multifocal leukoencephalopathy in patients without HIV
K. L. Amend et al.
NEUROLOGY (2010)
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases (vol 9, pg 438, 2010)
D. B. Clifford et al.
LANCET NEUROLOGY (2010)
Progressive Multifocal Leukoencephalopathy A National Estimate of Frequency in Systemic Lupus Erythematosus and Other Rheumatic Diseases
Eamonn S. Molloy et al.
ARTHRITIS AND RHEUMATISM (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort Study
Frederik Neess Engsig et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
Adrian Egli et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Monoclonal antibodies and progressive multifocal leukoencephalopathy
Joseph R. Berger et al.
MABS (2009)
Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells
Souichi Nukuzuma et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
Reemergence of PML in Natalizumab-Treated Patients - New Cases, Same Concerns
Eugene O. Major
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Progressive Multifocal Leukoencephalopathy and Use of Mycophenolate Mofetil After Kidney Transplantation
Robert T. Neff et al.
TRANSPLANTATION (2008)
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Grappo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
Andrea Gallamini et al.
BLOOD (2007)
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring
Ludwig Kappos et al.
LANCET NEUROLOGY (2007)
JC virus detection in bodily fluids: Clues to transmission
Joseph R. Berger et al.
CLINICAL INFECTIOUS DISEASES (2006)
Infectious complications associated with alemtuzumab use for lymphoproliferative disorders
Stanley I. Martin et al.
CLINICAL INFECTIOUS DISEASES (2006)
Costimulation blockade with belatacept in renal transplantation
F Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis
S Wickham et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
The human polyomavirus, JCV, uses serotonin receptors to infect cells
GF Elphick et al.
SCIENCE (2004)
A novel targeted T-cell modulator, efalizumab, for plaque psoriasis
M Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
WA Knowles et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: Is there a biological explanation?
SK Shankar et al.
JOURNAL OF NEUROVIROLOGY (2003)
Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: Explaining the high incidence and disproportionate, frequency of the illness relative to other immunosuppressive conditions
JR Berger
JOURNAL OF NEUROVIROLOGY (2003)